Developer of a microbial biotechnology platform designed to change production models of high-value molecules. Abolis is based in Paris, France. Its last known valuation is $53.1 million. It has raised $40.1 million.
Last price · $/share
—
Implied valuation
$53.1M
Total raised
$40.1M
Last round
—
Cap table — not yet on record
Abolis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Abolis with a free account
·Watch Abolis: the Monday email on marks, rounds and moves
